Arner P, Gunnarsson R, Blomdahl S, Groth C G
Diabetes Care. 1983 Jan-Feb;6(1):23-5. doi: 10.2337/diacare.6.1.23.
Risk factors and course of steroid diabetes were investigated in 145 renal-transplant recipients who were given a high-dose steroid regimen. Persistent steroid diabetes developed in 25% of the patients and transient diabetes in another 22%. When antidiabetic therapy was required, insulin had to be given in 50%. The incidence of steroid diabetes correlated with steroid dose, age, body weight, and diabetes heredity but not with abnormal glucose tolerance or with another complication of steroid therapy, posterior-pole lenticular cataract. There was no association with HLA-A and B antigens. Thus, steroid diabetes is a frequent complication of high-dose corticosteroid therapy and is similar to type II diabetes. However, it often requires insulin therapy.
对145例接受大剂量类固醇治疗方案的肾移植受者的类固醇糖尿病的危险因素及病程进行了调查。25%的患者出现持续性类固醇糖尿病,另有22%出现短暂性糖尿病。当需要抗糖尿病治疗时,50%的患者必须使用胰岛素。类固醇糖尿病的发病率与类固醇剂量、年龄、体重和糖尿病遗传因素相关,但与糖耐量异常或类固醇治疗的另一种并发症后极部晶状体混浊无关。与HLA - A和B抗原无关联。因此,类固醇糖尿病是大剂量皮质类固醇治疗常见的并发症,与II型糖尿病相似。然而,它常常需要胰岛素治疗。